Health Highlights: July 18, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Good Health is Your Greatest Wealth……Virgil
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Previous Harvard studies found failing to engage in the recommended 30 minutes of exercise daily was the main cause of 6 to 10 percent of coronary heart disease, breast cancer, colon cancer and type two diabetes around the world. If exercise simply …
See all stories on this topic »
On a recent trip to Mexico, my plan was to hit the hotel gym so that I could keep up with my exercise regimen. Turns out, the hotel didn't have one! But if there's one thing I've learned on this journey, it's that there's always a way to squeeze in a … See all stories on this topic » |
Shape Magazine (blog) |
WASHINGTON, July 18, 2012 – Military Sealift Command fleet replenishment oiler USNS Henry J. Kaiser, which is providing logistical support for U.S. Pacific Fleet's biennial Rim of the Pacific exercise off Hawaii, yesterday delivered 900000 gallons of a …
See all stories on this topic »
The Navy is using today's exercise to test and evaluate the cross-platform utility and functionality of advanced biofuels in an operational setting. The "drop-in" fuel can easily blend with or can completely replace conventional fuels. These …
See all stories on this topic »
To ensure security, safety and cooperation, big nations like the United States, Canada, Japan and Australia are hosting the Rim of the Pacific Exercise, or RIMPAC. With exercises on and around the Hawaiian Islands, it is the world's largest …
See all stories on this topic »
WASHINGTON — A new weight–loss pill that many doctors consider the most effective of a new generation of anti-obesity drugs got the approval of the Food and Drug Administration on Tuesday. The pill, called Qsymia, was approved for patients who are …
See all stories on this topic »
FDA Grants Approval to Diet Pill From Vivus (WSJ): Approval of Vivus's weight–loss drug Qsymia marks the second approval of a new weight–loss drug in less than a month; the drugs, which require a doctor's prescription, won't be available until later … See all stories on this topic » |
Wall Street Journal (blog) |
A push to get more AIDS treatment to the world's poorest, hardest-hit countries is paying off as deaths inch down — and new infections are dropping a bit, too, the United Nations reported Wednesday.
More than eight million people — a record number in low- and middle-income countries — are now taking antiretroviral drugs to treat HIV, according to data released Wednesday by UNAIDS.